These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 21255370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.
    Morimoto K, Suzuki N, Tanida I, Kakuta S, Furuta Y, Uchiyama Y, Hanada K, Suzuki Y, Yamaji T.
    J Biol Chem; 2020 Jul 10; 295(28):9490-9501. PubMed ID: 32409578
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression.
    Shin IS, Ishii S, Shin JS, Sung KI, Park BS, Jang HY, Kim BW.
    BMB Rep; 2009 May 31; 42(5):310-4. PubMed ID: 19470247
    [Abstract] [Full Text] [Related]

  • 5. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
    Geyer PE, Maak M, Nitsche U, Perl M, Novotny A, Slotta-Huspenina J, Dransart E, Holtorf A, Johannes L, Janssen KP.
    Mol Cancer Ther; 2016 May 31; 15(5):1008-17. PubMed ID: 26826119
    [Abstract] [Full Text] [Related]

  • 6. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
    Raa H, Grimmer S, Schwudke D, Bergan J, Wälchli S, Skotland T, Shevchenko A, Sandvig K.
    Traffic; 2009 Jul 31; 10(7):868-82. PubMed ID: 19453975
    [Abstract] [Full Text] [Related]

  • 7. Shiga Toxin (Stx) Classification, Structure, and Function.
    Melton-Celsa AR.
    Microbiol Spectr; 2014 Aug 31; 2(4):EHEC-0024-2013. PubMed ID: 25530917
    [Abstract] [Full Text] [Related]

  • 8. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
    Warnier M, Römer W, Geelen J, Lesieur J, Amessou M, van den Heuvel L, Monnens L, Johannes L.
    Kidney Int; 2006 Dec 31; 70(12):2085-91. PubMed ID: 17063173
    [Abstract] [Full Text] [Related]

  • 9. Protection against Shiga Toxins.
    Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K.
    Toxins (Basel); 2017 Feb 03; 9(2):. PubMed ID: 28165371
    [Abstract] [Full Text] [Related]

  • 10. Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation.
    Storck W, Meisen I, Gianmoena K, Pläger I, Kouzel IU, Bielaszewska M, Haier J, Mormann M, Humpf HU, Karch H, Müthing J.
    Biol Chem; 2012 Aug 03; 393(8):785-99. PubMed ID: 22944681
    [Abstract] [Full Text] [Related]

  • 11. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
    Bergan J, Skotland T, Lingelem AB, Simm R, Spilsberg B, Lindbäck T, Sylvänne T, Simolin H, Ekroos K, Sandvig K.
    Cell Mol Life Sci; 2014 Nov 03; 71(21):4285-300. PubMed ID: 24740796
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic Uses of Bacterial Subunit Toxins.
    Lingwood C.
    Toxins (Basel); 2021 May 26; 13(6):. PubMed ID: 34073185
    [Abstract] [Full Text] [Related]

  • 13. Shiga toxin binding alters lipid packing and the domain structure of Gb3-containing membranes: a solid-state NMR study.
    Bosse M, Sibold J, Scheidt HA, Patalag LJ, Kettelhoit K, Ries A, Werz DB, Steinem C, Huster D.
    Phys Chem Chem Phys; 2019 Jul 17; 21(28):15630-15638. PubMed ID: 31268447
    [Abstract] [Full Text] [Related]

  • 14. Membrane invagination induced by Shiga toxin B-subunit: from molecular structure to tube formation.
    Pezeshkian W, Hansen AG, Johannes L, Khandelia H, Shillcock JC, Kumar PB, Ipsen JH.
    Soft Matter; 2016 Jun 21; 12(23):5164-71. PubMed ID: 27070906
    [Abstract] [Full Text] [Related]

  • 15. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.
    Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Müthing J.
    Cell Mol Life Sci; 2013 Feb 21; 70(3):425-57. PubMed ID: 22766973
    [Abstract] [Full Text] [Related]

  • 16. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
    Ashkenazi S, Cleary TG.
    J Clin Microbiol; 1989 Jun 21; 27(6):1145-50. PubMed ID: 2666433
    [Abstract] [Full Text] [Related]

  • 17. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
    Luginbuehl V, Meier N, Kovar K, Rohrer J.
    Biotechnol Adv; 2018 Jun 21; 36(3):613-623. PubMed ID: 29432805
    [Abstract] [Full Text] [Related]

  • 18. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains.
    Katagiri YU, Mori T, Nakajima H, Katagiri C, Taguchi T, Takeda T, Kiyokawa N, Fujimoto J.
    J Biol Chem; 1999 Dec 03; 274(49):35278-82. PubMed ID: 10575015
    [Abstract] [Full Text] [Related]

  • 19. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.
    Couture O, Dransart E, Dehay S, Nemati F, Decaudin D, Johannes L, Tanter M.
    Mol Imaging; 2011 Apr 03; 10(2):135-43. PubMed ID: 21439258
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells.
    Torgersen ML, Engedal N, Pedersen AM, Husebye H, Espevik T, Sandvig K.
    FEMS Immunol Med Microbiol; 2011 Feb 03; 61(1):63-75. PubMed ID: 21054580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.